TrialLancet (London, England)2011

Antigen-based therapy with glutamic acid decarboxylase (GAD) vaccine in patients with recent-onset type 1 diabetes: a randomised double-blind trial.

Diane K Wherrett et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.